A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.
Saved in:
| Title: | A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. |
|---|---|
| Authors: | Pandey K; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Wang SS; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Children's Cancer Centre, Royal Children's Hospital, Parkville, VIC, Australia., Mifsud NA; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Faridi P; Monash Proteomics and Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; School of Clinical Sciences, Department of Medicine, Monash University, Clayton, VIC, Australia.; Department of Medicine, Sub-Faculty of Clinical and Molecular Medicine, Faculty of Medicine, Nursing & Health Sciences, Monash University, Clayton, VIC, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC, Australia.; Department of Molecular and Translational Medicine, School of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia., Davenport AJ; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Webb AI; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Sandow JJ; Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Ayala R; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Monje M; Department of Neurology and Neurological Sciences and Howard Hughes Medical Institute, Stanford University, Stanford, CA, United States., Cross RS; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Ramarathinam SH; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Jenkins MR; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; The Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.; LaTrobe Institute for Molecular Science, LaTrobe University, Bundoora, VIC, Australia., Purcell AW; Department of Biochemistry and Molecular Biology and Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Aug 11; Vol. 13, pp. 1192448. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
